We describe an unusual case of SPENCD due to two hitherto unknown mutations in the ACP5 gene leading to complete loss of TRAP activity in the patient’s serum. The gene discussed is CD40LG; the disease is Spondyloenchondrodysplasia with immune dysregulation.